Dhealthwellness.com – If your child is suffering from psoriasis, there are a number of treatment options available to you. These treatments range from topical therapies to a course of medication. However, there is no one treatment that works for every child, and you should always seek a medical opinion before deciding which treatment to use.
Skin Conditions Affecting the Immune System
When a child is diagnosed with psoriasis, a physical exam is often conducted. The doctor will ask the child about their family’s health history and will examine the area of skin affected. They may also perform a complete check on the child’s skin, including the nails. This will help the doctor determine if the child has a chronic infection. Psoriasis is a skin condition that affects the immune system. It causes red, scaly rashes. Symptoms can vary in severity and duration. Fortunately, there are several different treatment options.
Medications used to treat psoriasis may include antibiotics, topical steroids, or medications activated by special lights. These medications should be applied under supervision to avoid the possibility of allergic reactions. A physical exam for psoriasis is also performed to ensure that the patient is not suffering from other diseases or comorbidities. During this examination, the dermatologist will perform a series of tests to determine the nature of the patient’s skin disease. Some tests may involve a skin biopsy.
The pathophysiology of psoriasis is complex and involves a number of immunologic alterations in the skin. In psoriasis, the overactive immune system is believed to be responsible for the inflammation that occurs. Psoriasis is a chronic, genetically determined inflammatory skin disease. It shares a genetic link with rheumatoid arthritis and multiple sclerosis. Although the genetics of psoriasis are not completely understood, a number of genomic loci are implicated in the development of the disease.
Chronic and Non-Communicable Skin Diseases
Another key player in the pathophysiology of psoriasis are neutrophils. When these cells encounter bacterial proteins, they release DNA. Upon activation, they form a complex known as DNA-LL-37. If you have a child with psoriasis, you may be wondering what treatment options are available. Psoriasis is a chronic, non-contagious skin disease that causes thick, red patches to appear on the skin. It can affect any part of the body.
Psoriasis is caused by a number of factors. It is believed to be triggered by a complex abnormality of the immune system. The condition usually starts with a patch on the skin, but can also occur on the nails. Treatment options for psoriasis are aimed at easing the symptoms of the disease and preventing flare-ups. Topical treatments are typically the first line of therapy for mild to moderate psoriasis. These include topical steroid creams and calcipotriol.
Systemic Treatments Used for Severe Forms of Psoriasis
Systemic treatments are used for severe forms of psoriasis. These drugs are categorized as biologics, which target cytokines. Biological agents have been tested only in patients with severe psoriasis. Among the biological agents for pediatric psoriasis, the three FDA-approved drugs are cyclosporine (CYA), ustekinumab, and etanercept. However, more clinical trials are needed to prove their efficacy in children.
The global pediatric psoriasis market is expected to grow at a CAGR of 8.7% from 2022 to 2028. Growing demand for advanced medications and R&D activities are key drivers for the market. However, lack of awareness among patients in developing countries and lack of funding may restrict the market. Despite this, the industry is estimated to experience lucrative growth. This is driven by the growing prevalence of the disease, increasing awareness among patients, and the increasing incidence of pediatric psoriasis in various regions across the world. In addition, the growing trend of custom medication will also contribute to the market’s expansion.
A number of research companies have been investing in the development of new medications. These medications are expected to provide promising clinical outcomes and propel the market’s growth in the near future. The psoriasis drugs market is moderately competitive. Key players include Amgen Inc., Biogen Idec, and Johnson & Johnson Services, Inc. Some of the other prominent players include AbbVie, Arcutis, Inc., Boehringer Ingelheim, Ltd., and Novartis Cosentyx.